Organogenesis Holdings Inc (ORGO)

NASDAQ HEALTHCARE
$2.37 -3.27% Daily RSI (14) 44 Neutral As of Jul 31, 2026 Add Alert

Moving Averages

SMA 200
$3.59
Price below

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$308.82M
P/E Ratio
None
EPS
$-0.12
Beta
1.329
Dividend Yield
0.00%
52-Week High
$7.08
52-Week Low
$2.04

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

Data last updated: July 14, 2026 at 1:39 AM EDT

Track ORGO for free

Get e-mail RSI alerts when Organogenesis Holdings Inc enters oversold or overbought territory. Free forever.

Add Alert